Cancer Epidemiology (CE) The goal of the Cancer Epidemiology (CE) Program is to provide a platform to synergize research efforts of epidemiologic and clinical researchers in order to elucidate pathways to cancer occurrence and progression that can impact clinical treatment and prevention strategies. The program brings together experienced, NCI- funded epidemiologists, molecular biologists, biostatisticians, bioinformaticists and NCCC clinicians around 3 central interactive program themes: (1) population genomics, (2) emerging risk factors, and (3) life course epidemiology. Program investigators design, execute, and analyze population-based research aimed at understanding cancer etiology, second malignancies, progression, and survival, as well as develop novel methods for these lines of research. This work is based on outstanding efforts to use population-based studies of the catchment area population and also to engage in research with national and international epidemiologic resources, including clinical trials, cohort and case-control studies. Currently there are 22 members, including 3 clinical members and 1 joint member, spanning 11 departments with expertise and experience in all facets of modern molecular epidemiology. The NCCC has been instrumental in supporting the efforts of the CE program, most notably with its support of strategic, targeted recruitment efforts, including the recruitment of Chris Amos, Olga Gorlova, Jennifer Doherty, Diane Gilbert-Diamond, Scott Williams, Amarendra Das, Zhigang Li, Brock Christensen and Carmen Marsit, the latter who serves now as Co-Director of the program with Margaret Karagas. Spurred by these recruitments and their synergies with existing member interests, the present program has developed and evolved, from a broader program in Cancer Epidemiology and Chemoprevention, to focus its efforts on cancer epidemiology research and translation. The program aims to expand collaborative research efforts within its membership and across NCCC Programs, utilizing monthly program meetings to encourage these activities, which are subsequently catalyzed by pilot grants funded by NCCC. The support of the NCCC was paramount in the successful creation and funding of the new COBRE Center for Molecular Epidemiology, the development of an interdisciplinary training program in the Quantitative Population Sciences in Cancer, and a second COBRE in Integrative Biology. These initiatives have been instrumental in the recruitment of talented faculty and trainees that continue to energize and grow cancer epidemiology research. More than 580 cancer-related articles have been published over the reporting period (85 [15%] in high impact journals), with all 22 members on intra-program (158=27%) and 19 members on inter- program (74=13%) collaborations. Total funding for the program is currently $11.5M, of which $10.8M is peer- reviewed and $2.9M is from NCI. These efforts will allow the CE program to continue to perform cutting-edge molecular epidemiologic research, on the etiology and outcomes of cancer, to reduce the burden of human malignancies and impact prevention and treatment strategies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023108-40
Application #
9616828
Study Section
Subcommittee I - Career Development (NCI)
Project Start
Project End
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
40
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Shee, Kevin; Jiang, Amanda; Varn, Frederick S et al. (2018) Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer. FASEB J :fj201801241R
Rodriguez-Garcia, Marta; Fortier, Jared M; Barr, Fiona D et al. (2018) Aging impacts CD103+ CD8+ T cell presence and induction by dendritic cells in the genital tract. Aging Cell 17:e12733
Shajani-Yi, Zahra; de Abreu, Francine B; Peterson, Jason D et al. (2018) Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing. Neoplasia 20:256-262
Szczepiorkowski, Zbigniew M; Burnett, Christine A; Dumont, Larry J et al. (2018) Apheresis buffy coat collection without photoactivation has no effect on apoptosis, cell proliferation, and total viability of mononuclear cells collected using photopheresis systems. Transfusion 58:943-950
Bossé, Yohan; Amos, Christopher I (2018) A Decade of GWAS Results in Lung Cancer. Cancer Epidemiol Biomarkers Prev 27:363-379
Pande, Mala; Joon, Aron; Brewster, Abenaa M et al. (2018) Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies. PLoS One 13:e0196245
Smith, T Jarrod; Sondermann, Holger; O'Toole, George A (2018) Co-opting the Lap System of Pseudomonas fluorescens To Reversibly Customize Bacterial Cell Surfaces. ACS Synth Biol 7:2612-2617
Gorlova, Olga Y; Li, Yafang; Gorlov, Ivan et al. (2018) Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations. PLoS One 13:e0189498
Schmit, Stephanie L; Edlund, Christopher K; Schumacher, Fredrick R et al. (2018) Novel Common Genetic Susceptibility Loci for Colorectal Cancer. J Natl Cancer Inst :
Cai, Yunliang; Wu, Shaoju; Zhao, Wei et al. (2018) Concussion classification via deep learning using whole-brain white matter fiber strains. PLoS One 13:e0197992

Showing the most recent 10 out of 1911 publications